Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-21 Purchase | 2025-05-21 9:23 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.3995 | $43,995 | 2,325,731 (Direct) | View |
| 2025-05-16 Purchase | 2025-05-19 5:13 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 20,000 | $4.2236 | $84,472 | 2,315,731 (Direct) | View |
| 2025-03-06 Purchase | 2025-03-06 5:53 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.015 | $50,150 | 2,295,731 (Direct) | View |
| 2025-03-05 Purchase | 2025-03-05 5:19 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.02 | $50,200 | 2,285,731 (Direct) | View |
| 2025-03-03 Purchase | 2025-03-04 4:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.705 | $47,050 | 2,275,731 (Direct) | View |
| 2025-02-28 Purchase | 2025-02-28 5:30 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.76 | $47,600 | 2,361,730 (Direct) | View |
| 2025-02-27 Purchase | 2025-02-27 4:13 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.76 | $47,600 | 2,351,730 (Direct) | View |
| 2025-02-26 Purchase | 2025-02-26 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.765 | $47,650 | 2,341,730 (Direct) | View |
| 2025-02-25 Purchase | 2025-02-25 7:38 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.464 | $44,640 | 2,331,730 (Direct) | View |
| 2025-02-21 Purchase | 2025-02-24 7:04 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,000 | $4.3894 | $8,779 | 356,398 (Indirect Direct) | View |
| 2024-11-14 Sale | 2024-11-18 5:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,000 | $5.1726 | $25,863 | 44,857 (Direct) | View |
| 2024-07-29 Sale | 2024-07-29 5:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,251 | $5.9203 | $13,327 | 229,398 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:50 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 17,088 | $4.2903 | $73,313 | 196,825 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:48 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 16,727 | $4.2997 | $71,921 | 129,789 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:47 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 55,172 | $4.193 | $231,339 | 1,871,730 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 14,700 | $4.3124 | $63,393 | 231,649 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 17,411 | $4.2145 | $73,379 | 313,569 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-05 Option Award | 2025-06-09 5:36 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 59,225 | $0 | 104,082 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:35 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 59,225 | $0 | 123,350 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:35 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 59,225 | $0 | 177,454 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:34 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 59,225 | $0 | 123,469 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 5:34 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 59,225 | $0 | 119,067 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:46 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 15,520 | $4.76 | 239,269 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:46 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 26,941 | $4.76 | 411,628 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 95,999 | $4.76 | 2,275,731 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 26,941 | $4.76 | 329,457 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:44 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 26,941 | $4.76 | 294,884 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 8:21 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 125,000 | $0 | 254,789 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 7:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 450,000 | $0 | 2,321,730 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 7:44 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 125,000 | $0 | 354,398 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 7:44 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 125,000 | $0 | 438,569 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 7:43 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 125,000 | $0 | 321,825 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:43 pm | N/A 2034-05-21 | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 62,089 | $0 | 104,327 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:55 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director | 58,107 | $0 | 101,822 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:53 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 58,107 | $0 | 155,807 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:53 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 58,107 | $0 | 87,435 (Direct) | View |
| 2024-05-17 Option Award | 2024-05-21 4:52 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 58,107 | $0 | 97,420 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:53 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel | 125,000 | $0 | 213,913 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer | 32,700 | $0 | 146,516 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 125,000 | $0 | 246,349 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 450,000 | $0 | 1,926,902 (Direct) | View |